[Form 4] UMH Properties, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Samuel A. Landy, who serves as President, CEO and a director of UMH Properties, Inc. (UMH), reported an insider sale on 09/03/2025. The Form 4 shows a sale of 10,000 shares at $15.25 per share. After the reported sale, Mr. Landy retained a direct beneficial holding reported as 1,091,282.87 shares and multiple indirect holdings including 12,068.99 shares held by his spouse, 41,317.15 held with his spouse, 49,295.19 in the Landy 2022 Family Trust, and 48,000 via EWL Grandchildren Fund LLC (co-manager). The filing also lists outstanding derivative holdings exercisable into common stock: 29,500, 50,000, 50,000, and 50,000 options with exercise prices and expiration dates as shown in the form. The form is signed on 09/04/2025.
Positive
- Comprehensive disclosure of direct and indirect holdings including trusts and spouse-held shares
- Substantial retained ownership: 1,091,282.87 shares reported direct after sale
- Detailed option schedules disclosed with exercise prices and expirations
Negative
- Insider sale of 10,000 shares at $15.25 which reduces insider shareholding by that amount
Insights
TL;DR: Routine insider sale of 10,000 shares; large residual direct ownership remains, plus significant exercisable options.
The transaction reported is a straightforward sale of 10,000 shares at $15.25 each. Post-sale direct beneficial ownership remains substantial at 1,091,282.87 shares, indicating continued significant insider exposure to UMH equity. The report also discloses four sets of exercisable options totaling 179,500 underlying shares, each with specific exercise prices and expirations listed, which could dilute equity upon exercise but are standard for executive compensation. Based solely on the filing, this appears to be a non-event in terms of changing control or governance.
TL;DR: Disclosure is complete for the reported sale and existing holdings; no governance changes or departures reported.
The Form 4 clearly identifies the reporting persons roles as President, CEO and director and provides a granular breakdown of direct and indirect holdings, including trusts and family-held positions. The sale is documented with price and amount and the form lists multiple option grants with exercise details, satisfying Section 16 disclosure norms. There are no indications of resignations, plan-based transactions, or changes in relationship to the issuer in this filing.